Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (2), 257-262
- https://doi.org/10.1016/0006-2952(86)90523-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Modification of platelet function and arachidonic acid metabolism by bioflavonoidsBiochemical Pharmacology, 1984
- HPLC Separation and Quantitative Determination of Biflavones in Leaves fromGinkgo bilobaPlanta Medica, 1983
- Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclinBiochemical Pharmacology, 1982
- Pentasubstituted quercetin analogs as selective inhibitors of particulate 3',5'-cyclic-AMP phosphodiesterase from rat brainJournal of Medicinal Chemistry, 1982
- Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: Structure-activity relationshipsInflammation Research, 1982
- Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compoundsBiochemical Pharmacology, 1981
- Inhibition of 3',5'–AMP Phosphodiesterase by Biflavonoids and XanthonesPlanta Medica, 1979
- Flavonoids are selective cyclic GMP phosphodiesterase inhibitorsBiochemical Pharmacology, 1979
- Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesteraseCellular and Molecular Life Sciences, 1978
- Elevation of cyclic AMP level in Ehrlich ascites tumor cells by quercetinBiochemical Pharmacology, 1977